These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 10221366)
1. Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity. Guay DR Pharmacotherapy; 1999 Mar; 19(3):267-80. PubMed ID: 10221366 [TBL] [Abstract][Full Text] [Related]
2. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Abrams P; Freeman R; Anderström C; Mattiasson A Br J Urol; 1998 Jun; 81(6):801-10. PubMed ID: 9666761 [TBL] [Abstract][Full Text] [Related]
3. Tolterodine use for symptoms of overactive bladder. Ruscin JM; Morgenstern NE Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221 [TBL] [Abstract][Full Text] [Related]
5. Which anticholinergic drug for overactive bladder symptoms in adults. Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963 [TBL] [Abstract][Full Text] [Related]
6. Which anticholinergic drug for overactive bladder symptoms in adults. Hay-Smith J; Herbison P; Ellis G; Morris A Cochrane Database Syst Rev; 2005 Jul; (3):CD005429. PubMed ID: 16034974 [TBL] [Abstract][Full Text] [Related]
7. Tolterodine: a review of its use in the treatment of overactive bladder. Clemett D; Jarvis B Drugs Aging; 2001; 18(4):277-304. PubMed ID: 11341475 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatment for detrusor overactivity. Lai HH; Boone TB; Appell RA Curr Urol Rep; 2002 Oct; 3(5):365-72. PubMed ID: 12354344 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Drutz HP; Appell RA; Gleason D; Klimberg I; Radomski S Int Urogynecol J Pelvic Floor Dysfunct; 1999; 10(5):283-9. PubMed ID: 10543335 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Appell RA Urology; 1997 Dec; 50(6A Suppl):90-6; discussion 97-9. PubMed ID: 9426760 [TBL] [Abstract][Full Text] [Related]
11. Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis. Harvey MA; Baker K; Wells GA Am J Obstet Gynecol; 2001 Jul; 185(1):56-61. PubMed ID: 11483904 [TBL] [Abstract][Full Text] [Related]
12. Tolterodine: a safe and effective treatment for older patients with overactive bladder. Malone-Lee JG; Walsh JB; Maugourd MF J Am Geriatr Soc; 2001 Jun; 49(6):700-5. PubMed ID: 11454106 [TBL] [Abstract][Full Text] [Related]
13. Tolterodine: a clinical review. Crandall C J Womens Health Gend Based Med; 2001 Oct; 10(8):735-43. PubMed ID: 11703885 [TBL] [Abstract][Full Text] [Related]
14. Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET). Sussman D; Garely A Curr Med Res Opin; 2002; 18(4):177-84. PubMed ID: 12201616 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity. Ethans KD; Nance PW; Bard RJ; Casey AR; Schryvers OI J Spinal Cord Med; 2004; 27(3):214-8. PubMed ID: 15478523 [TBL] [Abstract][Full Text] [Related]
16. Tolterodine for the treatment of overactive bladder: a review. Rovner ES Expert Opin Pharmacother; 2005 Apr; 6(4):653-66. PubMed ID: 15934891 [TBL] [Abstract][Full Text] [Related]
17. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial. Appell RA Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340 [No Abstract] [Full Text] [Related]
18. The newer antimuscarinic drugs: bladder control with less dry mouth. Appell RA Cleve Clin J Med; 2002 Oct; 69(10):761, 765-6, 768-9. PubMed ID: 12371799 [TBL] [Abstract][Full Text] [Related]
19. Benefit-risk assessment of tolterodine in the treatment of overactive bladder in adults. Garely AD; Burrows L Drug Saf; 2004; 27(13):1043-57. PubMed ID: 15471509 [TBL] [Abstract][Full Text] [Related]
20. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]